bronchial asthma

Dr. MULINZI SOLOMON

This document provides a detailed explanation of bronchial asthma, defining it as a chronic inflammatory airway disorder characterized by recurrent symptoms and variable airflow limitation. It delves into the global and Ugandan epidemiology, highlighting high prevalence and uncontrolled symptoms in adolescents. The pathophysiology, including bronchoconstriction and airway remodeling, is explained, along with various classifications based on triggers and severity. Management strategies focus on symptom control, reducing exacerbations, preserving lung function, and minimizing adverse effects through patient education, trigger avoidance, monitoring, and pharmacologic therapy.